These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24305420)

  • 1. Why commercialization of gene therapy stalled; examining the life cycles of gene therapy technologies.
    Ledley FD; McNamee LM; Uzdil V; Morgan IW
    Gene Ther; 2014 Feb; 21(2):188-94. PubMed ID: 24305420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry.
    Bertram TA; Tentoff E; Johnson PC; Tawil B; Van Dyke M; Hellman KB
    Tissue Eng Part A; 2012 Nov; 18(21-22):2187-94. PubMed ID: 22838399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of Innovation in Alzheimer's Disease Drug Development: A Strategic Assessment Based on Technological Maturity.
    Beierlein JM; McNamee LM; Walsh MJ; Ledley FD
    Clin Ther; 2015 Aug; 37(8):1643-51.e3. PubMed ID: 26243074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commercialization of gene therapy drugs.
    Irfan-Maqsood M; Bahrami AR; Matin MM; Khan MA
    J Coll Physicians Surg Pak; 2013 Dec; 23(12):908. PubMed ID: 24305002
    [No Abstract]   [Full Text] [Related]  

  • 5. Translational science by public biotechnology companies in the IPO "class of 2000": the impact of technological maturity.
    McNamee L; Ledley F
    PLoS One; 2013; 8(12):e82195. PubMed ID: 24358154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Eating my hat?].
    Jordan B
    Med Sci (Paris); 2013 Oct; 29(10):923-5. PubMed ID: 24148134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell and gene therapy investment: evolution and future outlook on investor perspectives.
    Kunze-Küllmer M; Goonewardene A; Kili S; Theoharis S; Rivers P
    Cytotherapy; 2024 Jul; 26(7):672-680. PubMed ID: 38483363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biotechnology innovation machine: a source of intelligent biopharmaceuticals for the pharma industry--mapping biotechnology's success.
    Evens RP; Kaitin KI
    Clin Pharmacol Ther; 2014 May; 95(5):528-32. PubMed ID: 24448474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changing environment for technological innovation in health care.
    Goodman CS; Gelijns AC
    Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commercialization, patents and moral assessment of biotechnology products.
    Hoedemaekers R
    J Med Philos; 2001 Jun; 26(3):273-84. PubMed ID: 11445882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commercialization of nanotechnology.
    Hobson DW
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(2):189-202. PubMed ID: 20049790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Top Five Gene Therapy Stories of 2019.
    Flotte TR
    Hum Gene Ther; 2019 Jan; 30(1):1-2. PubMed ID: 30628861
    [No Abstract]   [Full Text] [Related]  

  • 14. The Cost of Biotech Innovation: Exploring Research and Development Costs of Cell and Gene Therapies.
    Sabatini MT; Chalmers M
    Pharmaceut Med; 2023 Sep; 37(5):365-375. PubMed ID: 37286928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commercialization of new biotechnology: a systematic review of 16 commercial case studies in a novel manufacturing sector.
    Paul MJ; Thangaraj H; Ma JK
    Plant Biotechnol J; 2015 Oct; 13(8):1209-20. PubMed ID: 26140440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hans Küpper discusses science and venture capital.
    Küpper H
    Drug Discov Today; 2004 Nov; 9(21):909-12. PubMed ID: 15501722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced Tissue Sciences Inc.: learning from the past, a case study for regenerative medicine.
    Pangarkar N; Pharoah M; Nigam A; Hutmacher DW; Champ S
    Regen Med; 2010 Sep; 5(5):823-35. PubMed ID: 20868336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Life support for life science innovation?
    Nat Biotechnol; 2007 Feb; 25(2):144. PubMed ID: 17287731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene Therapy Entering the Land of Oz.
    Wilson JM
    Hum Gene Ther Clin Dev; 2018 Dec; 29(4):171. PubMed ID: 30576251
    [No Abstract]   [Full Text] [Related]  

  • 20. The Business of DNA Nanotechnology: Commercialization of Origami and Other Technologies.
    Dunn KE
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31963295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.